Beyond RAS: The Role of Epidermal Growth Factor Receptor (EGFR) and its Network in the Prediction of Clinical Outcome During Anti-EGFR Treatment in Colorectal Cancer Patients

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|15|13|1225-1230

ISSN： 1389-4501

Source： Current Drug Targets, Vol.15, Iss.13, 2014-12, pp. : 1225-1230

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti-EGFR strategies as an incremental step for the treatment of colorectal cancer patients: moving from scientific evidence to clinical practice

By Scartozzi Mario   Pierantoni Chiara   Berardi Rossana   Squadroni Michela   Cascinu Stefano  

Expert Opinion on Therapeutic Targets, Vol. 10, Iss. 2, 2006-04 ,pp. : 281-287

Informa Healthcare

Access to resources Recommend Favorite

Molecular Predictors of Efficacy to Anti-EGFR Agents in Colorectal Cancer Patients

By  

Current Cancer Drug Targets, Vol. 10, Iss. 1, 2010-02 ,pp. : 68-79

Bentham Science Publishers

Access to resources Recommend Favorite

Poly-L-arginine and Dextran Sulfate-Based Nanocomplex for Epidermal Growth Factor Receptor (EGFR) siRNA Delivery: Its Application for Head and Neck Cancer Treatment

By Cho Hyun-Jong   Chong Saeho   Chung Suk-Jae   Shim Chang-Koo   Kim Dae-Duk  

Pharmaceutical Research, Vol. 29, Iss. 4, 2012-04 ,pp. : 1007-1019

Springer Publishing Company

Access to resources Recommend Favorite

Patient-Tailored Treatments with Anti-EGFR Monoclonal Antibodies in Advanced Colorectal Cancer: KRAS and Beyond

By  

Current Cancer Drug Targets, Vol. 12, Iss. 4, 2012-04 ,pp. : 316-328

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-EGFR Strategy for Colorectal Cancer: Searching for the Real Target

By  

Letters in Drug Design & Discovery, Vol. 3, Iss. 8, 2006-10 ,pp. : 541-543

Bentham Science Publishers

Access to resources Recommend Favorite